search
Back to results

Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh.

Primary Purpose

Anemia

Status
Completed
Phase
Not Applicable
Locations
Bangladesh
Study Type
Interventional
Intervention
Multiple micronutrient supplement (iron)
Sponsored by
The Hospital for Sick Children
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anemia focused on measuring iron deficiency anemia, hematologic disease, infancy, pediatrics, Sprinkles®, iron, micronutrient

Eligibility Criteria

6 Months - 24 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 6-24 months.
  • Hemoglobin concentration > =70 g/L.
  • Consuming at least one regular meal of complementary food per day.
  • Reportedly free from any acute or chronic illness.
  • Permanent resident of the village.
  • Not receiving any other form of iron supplementation.
  • Parental consent obtained.

Exclusion Criteria:

  • Severe anemia (hemoglobin concentration <70 g/L).

Sites / Locations

  • Research and Evaluation Division, BRAC

Outcomes

Primary Outcome Measures

hemoglobin concentration
adherence measured by the number of sachets used

Secondary Outcome Measures

Acceptability measured through interview with mothers
weaning food practice at treatment end and 6 months post-treatment
length and weight at treatment end and 6 months post-treatment
morbidity from diarrhea and acute respiratory infections at treatment end and 6 months post treatment

Full Information

First Posted
October 24, 2006
Last Updated
April 14, 2021
Sponsor
The Hospital for Sick Children
Collaborators
Heinz Endowments
search

1. Study Identification

Unique Protocol Identification Number
NCT00392418
Brief Title
Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh.
Official Title
The Effectiveness of Flexible Administration of Sprinkles® in a Mixed Population of Anemic and Non-anemic Infants and Young Children in Rural Bangladesh.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
May 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
March 2005 (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hospital for Sick Children
Collaborators
Heinz Endowments

4. Oversight

5. Study Description

Brief Summary
Millions of people worldwide are affected by iron deficiency anemia (IDA). IDA is a widespread serious public health problem, especially for infants in developing countries mainly because of inadequate intake of iron due to the poor bioavailability of dietary iron in predominately cereal based diets. One of the ways to combat iron deficiency anemia is by supplementation to targeted populations. Although iron drops have been used, they have been largely unsuccessful in reducing the prevalence of anemia because of compliance, distribution and supply issues. Sprinkles® are a new approach to iron delivery that is as efficacious as iron drops and more acceptable. For Sprinkles® to be implemented into nation-wide programs as a sustainable alternative to current iron supplementation approaches, an optimal model of use and distribution for Sprinkles® needs to be established. By comparing daily versus flexible use of Sprinkles® (60 sachets over 60, 90 and 120 days) among infants and young children aged 6-24 months, the primary objectives are to study the effect of the three administration models of Sprinkles® on changes in: hemoglobin concentration; and compliance or adherence to the intervention. ii. The secondary objective of this study is to determine the acceptability of each of the three intervention models. We hypothesize that adherence will be greater and hemoglobin concentration response will be higher in those given 'flexible' instructions to use all of the Sprinkles® supplied over a specific period of time compared to those given strict instructions for daily use.
Detailed Description
Study Design This study will follow a community-based cluster randomized clinical trial design involving three intervention groups. Total number of villages included in the study will be determined by the availability of the eligible children. In each village, all eligible children will be screened through house-to-house visits. After the screening, all the children will be randomized by village using a table with randomly assorted table into one of three groups: Daily use of 60 Sprinkles® sachets over 60 days. Flexible use of 60 Sprinkles® sachets over 90 days. Flexible use of 60 Sprinkles® sachets over 120 days. In all groups, assessments will be done at baseline, at the end of a group's intervention and at 6 months after intervention in each group for follow-up. The study will take place in Kaligong sub-district in Bangladesh. All villages in Kaligonj sub-district consist of plain agricultural land. Subsistence farming is the major source of livelihood. Rice is the commonly eaten staple mixed with lentil and vegetable curry and occasionally with pieces of fish and meat. Similar to the rest of the plain areas of the country, malnutrition among women and children is widespread, but malaria is extremely uncommon and the prevalence of hookworm is fairly low (less than 2%%).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anemia
Keywords
iron deficiency anemia, hematologic disease, infancy, pediatrics, Sprinkles®, iron, micronutrient

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Single
Allocation
Randomized
Enrollment
360 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Multiple micronutrient supplement (iron)
Primary Outcome Measure Information:
Title
hemoglobin concentration
Time Frame
at end of treatment and 6 months post-treatment
Title
adherence measured by the number of sachets used
Time Frame
end of treatment
Secondary Outcome Measure Information:
Title
Acceptability measured through interview with mothers
Title
weaning food practice at treatment end and 6 months post-treatment
Title
length and weight at treatment end and 6 months post-treatment
Title
morbidity from diarrhea and acute respiratory infections at treatment end and 6 months post treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
24 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 6-24 months. Hemoglobin concentration > =70 g/L. Consuming at least one regular meal of complementary food per day. Reportedly free from any acute or chronic illness. Permanent resident of the village. Not receiving any other form of iron supplementation. Parental consent obtained. Exclusion Criteria: Severe anemia (hemoglobin concentration <70 g/L).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stanley H Zlotkin, PhD
Organizational Affiliation
The Hospital for Sick Children, Toronto, Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
Research and Evaluation Division, BRAC
City
Dhaka
Country
Bangladesh

12. IPD Sharing Statement

Learn more about this trial

Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh.

We'll reach out to this number within 24 hrs